Revolution Medicines to Deliver Multiple Presentations at the 2025 American Association for Cancer Research (AACR) Annual Meeting
Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing targeted therapies for patients ...
Woman details the painful signs that led to her tongue cancer diagnosis at 35
Beth Riehle has gone viral for her TikTok "fit checks," which help her practice her speech after having 80% of her tongue ...
The American Journal of Managed Care4d
Understanding Primary and Secondary Nonadherence to Chronic Oral Medication
Medication nonadherence to oral anticoagulants and oral anti–prostate cancer medication has been scrutinized through new ...
Rolling Out4d
Alarming facts about HPV and oral cancer you should know
Medical experts reveal critical information about the growing link between HPV and oral cancer, prevention methods, and why ...
ScienceAlert on MSN5d
Oral Cancer Cases Are on The Rise, And Sugary Drinks Could Be to Blame
It may not just be tooth decay you need to worry about when it comes to sugary drinks: new research suggests that these ...
Starton Therapeutics to Present Poster at the American Association for Cancer Research (AACR) Annual Meeting 2025
Starton Therapeutics Inc. (“Starton” or the “Company”), a clinical-stage biotechnology company transforming standard-of-care therapies with proprietary dermal technologies, announced today that the ...
Auron Therapeutics Announces Poster Presentation at 2025 AACR Annual Meeting
Auron Therapeutics, a clinical-stage biotechnology company targeting cell-state plasticity to improve patient outcomes in oncology and inflammatory disease, today announced that the Company will ...